FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| Evofosfamide, 918633-87-1, Evofosfamide Intermediate 794492-64-1, stock 894.4g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply. |
| Evofosfamide, 918633-87-1, Evofosfamide Intermediate 107-21-1, stock 648.8g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
| Evofosfamide, 918633-87-1, Evofosfamide Intermediate 1698898-24-6, stock 110.5g, white powder, assay by HPLC 98.4%, HNMR, LCMS we supply. |
| Evofosfamide, 918633-87-1, Evofosfamide Intermediate 177760-04-2, stock 207.2g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |
| Evofosfamide, 918633-87-1, Evofosfamide Intermediate 39070-13-8, stock 569.6g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
| Evofosfamide, 918633-87-1, Evofosfamide Intermediate 50700-55-5, stock 791.8g, white powder, assay by HPLC 99%, HNMR, LCMS we supply. |
| Evofosfamide, 918633-87-1, Evofosfamide Intermediate 39070-14-9, stock 732.5g, white powder, assay by HPLC 98.5%, HNMR, LCMS we supply. |
| Evofosfamide, 918633-87-1, Evofosfamide Intermediate 141025-16-3, stock 170.5g, white powder, assay by HPLC 99.6%, HNMR, LCMS we supply. |
